ATCA is recruiting a healthcare advisory board member: an accomplished healthcare executive, physician leader, operator, or strategic advisor with a track record in clinical innovation, care model development, healthcare growth, or scalable service delivery. This is a board-level engagement for a leader who wants to help shape an Alzheimer’s clinical innovation network addressing one of the most urgent and underserved challenges in modern healthcare: cognitive decline, dementia, and neurodegenerative disease. About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America is building the national infrastructure for precision-based Alzheimer’s and dementia care. The model integrates proprietary AI, personalized treatment protocols, and a replicable specialty clinic platform purpose-built to identify the underlying drivers of neurodegeneration and deliver individualized interventions that measurably slow progression. ATCA’s flagship clinic in Palm Beach Gardens/Jupiter is fully operational, payer-integrated, and running at capacity with appointments booked months out. Additional clinics are in active development. The company is executing a disciplined national expansion backed by a multidisciplinary team of healthcare executives, neuroscientists, AI engineers, and clinical specialists. Why Now Proven Demand: The flagship clinic, positioned in a high-visibility corridor adjacent to Cleveland Clinic, reached full capacity rapidly, validating strong market demand for proactive Alzheimer’s and cognitive care. Payer Alignment: Services are reimbursed by Medicare, Medicare Advantage, and major commercial insurers, reducing adoption friction and supporting revenue growth. Demonstrated Outcomes: In a study using ATCA’s AI-driven protocol, 75% of patients with mild cognitive impairment showed no further cognitive decline, creating a meaningful clinical and strategic differentiator. Market Scale: ATCA is positioned within a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, with embedded research infrastructure that can support real-world evidence generation, partnerships, and additional revenue streams. Financial Model: The clinic platform is engineered to target strong EBITDA margins through optimized staffing, a high-acuity service mix, and reimbursement dynamics designed for repeatable multi-market expansion. Key Achievements Proprietary AI Precision Engine: ATCA has built and deployed a defensible AI-driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High-Margin, Replicable Clinic Platform: ATCA has developed a scalable specialty clinic model designed for repeatable expansion, supported by strong unit economics and multi-market rollout potential. Massive, Underserved Market Opportunity: The company is positioned to capture share in one of the largest and fastest-growing unmet-need categories in healthcare. Embedded Revenue and Innovation Infrastructure: Each clinic is designed not only to deliver patient care, but also to generate data, insights, research opportunities, partnerships, and long-term enterprise value.

Responsibilities

Include As a healthcare advisory board member, your contribution centers on four domains: Clinical Innovation Network Strategy: Advise on the development and strategic positioning of ATCA’s Alzheimer’s clinical innovation network, including differentiated care pathways, interdisciplinary collaboration models, innovation priorities, and the expansion of a connected platform for next-generation cognitive care. Scalable Clinical Model Development: Guide the standardization and replication of clinic operations across markets, including care pathway design, interdisciplinary structures, and systems that preserve quality while enabling sustainable growth. Payer, Partnership & Market Development: Provide guidance on reimbursement alignment, market positioning, partnership development, referral growth, and the strategic frameworks needed to support adoption and expansion of a clinically differentiated Alzheimer’s platform. Governance & Responsible Scaling: Advise on AI-enabled care delivery, digital health integration, strategic differentiation, and the governance infrastructure required to scale responsibly and credibly. Why Join Us? Board-Level Leverage: Bring meaningful strategic influence without day-to-day operational demands. Early-Stage Up